Cara Therapeutics, Inc.
NASDAQ:CARA
0.2918 (USD) • At close November 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -118.513 | -85.474 | -88.441 | 8.41 | -106.373 | -74.013 | -58.125 | -57.28 | -24.69 | -17.745 | -3.963 | -6.271 | -9.806 |
| Afschrijvingen & Amortisatie
| 0.259 | 0.248 | 0.248 | 0.209 | 0.198 | 0.37 | 0.495 | 1.465 | 0.839 | 0.783 | 0.789 | 1.021 | 1.17 |
| Uitgestelde Inkomstenbelasting
| -3.332 | 0 | 0.752 | -0.118 | -1.381 | -1.815 | -0.628 | -0.241 | -0.016 | 0 | 0 | 0.286 | -0.009 |
| Aandelen Gebaseerde Vergoedingen
| 13.73 | 17.734 | 20.785 | 14.835 | 12.568 | 9.478 | 5.793 | 2.8 | 2.514 | 1.371 | 0.123 | 0.061 | 0.095 |
| Verandering in Werkkapitaal
| 10.167 | -12.924 | 5.263 | -29.629 | -18.838 | 43.219 | -3.047 | 5.989 | 0.164 | -1.786 | 2.431 | -0.918 | 1.721 |
| Vorderingen
| 0.436 | -3.26 | 1.02 | -0.277 | -0.197 | -0.736 | 0.085 | -0.475 | -0.264 | 0 | 0 | 0.018 | 0 |
| Voorraden
| -0.438 | 0.201 | -2.584 | 0.277 | 0.197 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 3.275 | 5.679 | -1.02 | -2.784 | 6.043 | 5.116 | -3.027 | 6.265 | 3.322 | 0.722 | 0.722 | 0 | 0 |
| Overig Werkkapitaal
| 6.894 | -15.544 | 7.847 | -26.845 | -24.881 | 38.103 | -0.105 | 0.199 | 0.164 | -1.786 | 2.431 | -0.918 | 1.721 |
| Overige Niet-Contante Posten
| 5.611 | 1.686 | 1.306 | 0.806 | 4.601 | 0.46 | 0.057 | -0.355 | -0.305 | -0.265 | 3.449 | 0.076 | -0.025 |
| Kasstroom uit Operationele Activiteiten
| -92.078 | -78.73 | -60.087 | -5.487 | -109.225 | -22.301 | -54.827 | -47.381 | -21.478 | -17.642 | 2.829 | -6.031 | -6.845 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -2.375 | -0.043 | -0.039 | -0.349 | -0.018 | -0.073 | -0.058 | -0.717 | -0.02 | -0.042 | -0.005 | 0 | -0.015 |
| Netto Overnames
| -0.4 | 0.752 | 0.07 | -0.118 | -1.381 | -1.815 | 0.041 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -113.605 | -95.685 | -208.795 | -232.881 | -286.082 | -337.854 | -127.394 | -68.648 | -91.657 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 159.441 | 224.435 | 204.013 | 212.955 | 255.584 | 255.108 | 90.911 | 114.383 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0.4 | -0.752 | -4.712 | 0.118 | 1.381 | 1.815 | 0.741 | -0.769 | -91.657 | 0 | 0 | 0.511 | 0.06 |
| Kasstroom uit Investeringsactiviteiten
| 43.461 | 128.707 | -4.751 | -20.275 | -30.516 | -82.819 | -35.8 | 44.249 | -91.677 | -0.042 | -0.005 | 0.511 | 0.045 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| -36.474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.618 | -0.446 | -0.848 |
| Uitgifte van Gewone Aandelen
| 1.677 | 0.311 | 44.969 | 38.449 | 142.604 | 110.813 | 86.224 | 0.123 | 75.593 | 57.862 | 7.642 | 0.086 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 72.948 | 0.311 | 1.639 | 0.691 | 142.604 | 110.813 | 1.699 | 0.123 | 75.593 | 57.99 | 9.034 | 2.9 | 9.984 |
| Kasstroom uit Financieringsactiviteiten
| 38.151 | 0.311 | 46.608 | 39.14 | 142.604 | 110.813 | 87.923 | 0.123 | 75.593 | 57.99 | 8.416 | 2.54 | 9.136 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -11.966 | 50.288 | -18.23 | 13.378 | 2.863 | 5.693 | -2.704 | -3.009 | -37.562 | 40.306 | 11.24 | -2.98 | 2.336 |
| Kaspositie aan het Einde van de Periode
| 52.183 | 64.149 | 13.861 | 32.091 | 18.713 | 15.85 | 9.388 | 12.092 | 15.101 | 52.663 | 12.357 | 1.117 | 4.097 |